HARVARD BIOSCIENCE, INC. Operating Lease, Payments
HARVARD BIOSCIENCE, INC. (HBIO) reported Operating Lease, Payments of $1.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. operating lease, payments for the quarter ending 2026-06-30 was $641.00K, a 7.91% increase year-over-year.
- HARVARD BIOSCIENCE, INC. operating lease, payments for the quarter ending 2026-03-31 was $640.00K, a 7.38% increase year-over-year.
- HARVARD BIOSCIENCE, INC. operating lease, payments for the quarter ending 2025-12-31 was $659.00K, a 49.43% increase year-over-year.
- HARVARD BIOSCIENCE, INC. operating lease, payments for the quarter ending 2025-09-30 was $586.00K, a 0.51% increase year-over-year.
- HARVARD BIOSCIENCE, INC. operating lease, payments for fiscal 2025 was $2.44M, a 11.39% increase from fiscal 2024.
- HARVARD BIOSCIENCE, INC. operating lease, payments for fiscal 2024 was $2.19M, a 7.65% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. operating lease, payments for fiscal 2023 was $2.37M, a 0.85% increase from fiscal 2022.
- HARVARD BIOSCIENCE, INC. operating lease, payments for fiscal 2022 was $2.35M, a 0.76% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $641.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.28M 10-Q · filed 2026-08-11 | $1.94M derived: sum of 3 quarters · filed 2026-08-11 | $2.53M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $640.00K 10-Q · filed 2026-05-12 | $1.30M derived: sum of 2 quarters · filed 2026-05-12 | $1.89M derived: sum of 3 quarters · filed 2026-05-12 | $2.48M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $1.25M derived: sum of 2 quarters · filed 2026-03-13 | $1.84M derived: sum of 3 quarters · filed 2026-08-11 | $2.44M 10-K · filed 2026-03-13 |
| 2025-09-30 | $586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.18M derived: sum of 2 quarters · filed 2026-08-11 | $1.78M 10-Q · filed 2025-11-06 | $2.22M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $594.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.19M 10-Q · filed 2026-08-11 | $1.63M derived: sum of 3 quarters · filed 2026-08-11 | $2.21M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $596.00K 10-Q · filed 2026-05-12 | $1.04M derived: sum of 2 quarters · filed 2026-05-12 | $1.62M derived: sum of 3 quarters · filed 2026-05-12 | $2.19M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $1.02M derived: sum of 2 quarters · filed 2026-03-13 | $1.59M derived: sum of 3 quarters · filed 2026-03-13 | $2.19M 10-K · filed 2026-03-13 |
| 2024-09-30 | $583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.15M derived: sum of 2 quarters · filed 2025-11-06 | $1.75M 10-Q · filed 2025-11-06 | $2.35M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $565.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $1.16M 10-Q · filed 2025-08-11 | $1.76M derived: sum of 3 quarters · filed 2025-08-11 | $2.33M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $597.00K 10-Q · filed 2025-05-12 | $1.20M derived: sum of 2 quarters · filed 2025-05-12 | $1.76M derived: sum of 3 quarters · filed 2025-05-12 | $2.31M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $603.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $1.17M derived: sum of 2 quarters · filed 2025-03-14 | $1.71M derived: sum of 3 quarters · filed 2025-03-14 | $2.37M 10-K · filed 2025-03-14 |
| 2023-09-30 | $563.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.11M derived: sum of 2 quarters · filed 2024-11-08 | $1.76M 10-Q · filed 2024-11-08 | $2.35M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $548.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.20M 10-Q · filed 2024-08-08 | $1.79M derived: sum of 3 quarters · filed 2024-08-08 | $2.38M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $653.00K 10-Q · filed 2024-05-07 | $1.24M derived: sum of 2 quarters · filed 2024-05-07 | $1.83M derived: sum of 3 quarters · filed 2024-05-07 | $2.41M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.17M derived: sum of 2 quarters · filed 2024-03-07 | $1.75M derived: sum of 3 quarters · filed 2024-03-07 | $2.35M 10-K · filed 2024-03-07 |
| 2022-09-30 | $586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.17M derived: sum of 2 quarters · filed 2023-11-07 | $1.76M 10-Q · filed 2023-11-07 | $2.33M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $579.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.17M 10-Q · filed 2023-08-08 | $1.75M derived: sum of 3 quarters · filed 2023-08-08 | $2.48M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $594.00K 10-Q · filed 2023-04-26 | $1.17M derived: sum of 2 quarters · filed 2023-04-26 | $1.90M derived: sum of 3 quarters · filed 2023-04-26 | $2.35M derived: sum of 4 quarters · filed 2023-04-26 |
| 2021-12-31 | $574.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.30M derived: sum of 2 quarters · filed 2023-03-09 | $1.75M derived: sum of 3 quarters · filed 2023-03-09 | $2.37M 10-K · filed 2023-03-09 |
| 2021-09-30 | $730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.18M derived: sum of 2 quarters · filed 2022-11-09 | $1.79M 10-Q · filed 2022-11-09 | $2.47M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.06M 10-Q · filed 2022-08-04 | $1.74M derived: sum of 3 quarters · filed 2022-08-04 | $2.40M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $611.00K 10-Q · filed 2022-05-04 | $1.29M derived: sum of 2 quarters · filed 2022-05-04 | $1.95M derived: sum of 3 quarters · filed 2022-05-04 | $2.64M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.34M derived: sum of 2 quarters · filed 2022-03-11 | $2.03M derived: sum of 3 quarters · filed 2022-03-11 | $2.72M 10-K · filed 2022-03-11 |
| 2020-09-30 | $660.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $1.35M derived: sum of 2 quarters · filed 2021-11-05 | $2.04M 10-Q · filed 2021-11-05 | $2.76M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $694.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.38M 10-Q · filed 2021-08-06 | $2.10M derived: sum of 3 quarters · filed 2021-08-06 | $3.91M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $687.00K 10-Q · filed 2021-05-07 | $1.40M derived: sum of 2 quarters · filed 2021-05-07 | $3.22M derived: sum of 3 quarters · filed 2021-05-07 | $4.58M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $715.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $2.53M derived: sum of 2 quarters · filed 2021-03-17 | $3.90M derived: sum of 3 quarters · filed 2021-03-17 | $2.53M 10-K/A · filed 2021-03-17 |
| 2019-09-30 | $1.81M 10-Q · filed 2019-11-08 | $3.18M derived: sum of 2 quarters · filed 2019-11-08 | $1.81M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $1.37M 10-Q · filed 2019-08-08 | $1.37M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $702.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |